GSK-104020

Study Sponsor: GSK

Study Title

Blinded, randomised study to assess the immunogenicity and safety of GlaxoSmithKline (GSK) Biologicals’ live attenuated measles-mumps-rubella-varicella candidate vaccine when given to healthy children in their second year of life

Medicine or Vaccine (generic name)

Combined Measles, Mumps, Rubella, Varicella Vaccine

Sponsor Identification Number

104020

Trial Registry Identification Number(#'s)

NCT00126997 2004-005123-18

Medical Condition

Measles; Mumps; Rubella; Varicella

Phase

Phase 4

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=104020

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00126997

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2004-005123-18

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

An annotated case report form is not available for this study. A blank case report form will be provided.

Date Added to this Site

October 2014